• Phosphatase Inhibitor Cocktail 2: Assay Guide

  2026-09-20

  Learn how Phosphatase Inhibitor Cocktail 2 (100X in ddH2O), SKU K1013, supports protein phosphorylation preservation in lysates linked to viability, proliferation, and cytotoxicity studies. This scenario-based guide covers compatibility, dilution, interpretation, and practical reagent selection.

• Lipid Peroxidation (MDA) Assay Kit: Ferroptosis Insight

  2026-09-19

  Discover how the Lipid Peroxidation (MDA) Assay Kit converts malondialdehyde measurement into mechanistic evidence for ferroptosis research. This guide connects assay chemistry, orthogonal endpoints, and doxorubicin-induced liver injury to improve experimental interpretation.

• Ferrostatin-1 (Fer-1) in Ferroptosis Assays

  2026-09-18

  Ferrostatin-1 (Fer-1) provides a practical rescue tool for distinguishing lipid-peroxidation-driven cell death from nonspecific toxicity. This guide shows how to integrate Fer-1 into ferroptosis assays, cancer biology research, neurodegenerative disease models, and plant pathogen studies while avoiding common interpretation and handling errors.

• Moxifloxacin Beyond Antibacterial Benchmarking

  2026-09-18

  Moxifloxacin is more than a broad-spectrum fluoroquinolone antibiotic: it is a useful translational probe for connecting bacterial DNA gyrase biology with mammalian cell stress, antibiotic toxicity research, and metabolic response. This article places the compound alongside mechanistic insights from gepotidacin research and provides a practical framework for designing better bacterial, cellular, and animal studies.

• Masitinib (AB1010) Workflow Guide

  2026-09-17

  Masitinib (AB1010) is a DMSO-compatible phenylaminothiazole-type tyrosine kinase inhibitor for controlled studies of KIT, PDGFRα, PDGFRβ, mast cells, and selected GIST models. This guide outlines practical setup and QC considerations for research workflows, while excluding aqueous or ethanol-based protocols, broad-spectrum kinase screening, and clinical treatment decisions.

• BoNT/A, SOCS3, and Ocular Angiogenesis

  2026-09-17

  This study identifies botulinum neurotoxin serotype A as an inhibitor of laser-induced choroidal neovascularization and links its activity to suppression of retinal glial activation through SOCS3. The findings expand angiogenesis research beyond direct endothelial targeting while highlighting the need for additional validation in chronic and human disease settings.

• Catalpol (Catalpinoside): Mechanisms and Models

  2026-09-16

  Catalpol, also indexed as Catalpinoside, is a Rehmannia-derived iridoid glycoside used in cell and animal research. Evidence from an LPS-induced septic-associated encephalopathy study links it to NF-κB suppression, TrkB activation, BDNF enhancement, and improved cognitive outcomes.

• Adipogenic Reprogramming Limits PDAC Metastasis

  2026-09-16

  A 2026 Cell Death and Disease study shows that adipogenic transdifferentiation can redirect EMT-high pancreatic ductal adenocarcinoma cells into a post-mitotic, adipocyte-like state. In cell and mouse models, this fate conversion reduced proliferative and metastatic programs, providing a plasticity-oriented alternative to directly inhibiting EMT.

• FGF19–ELF4 Signaling Drives Colorectal Cancer Metastasis

  2026-09-15

  The reference study identifies ELF4 as a clinically relevant transcriptional driver of colorectal cancer metastasis and places it within an FGF19–ERK1/2–SP1 signaling axis. Its findings connect ELF4 to direct activation of FGFR4 and SRC, while combined pathway inhibition provides a mechanistic rationale for limiting metastatic progression.

• Ginsenoside Rg1: Neuroimmune Research Workflow

  2026-09-15

  Build reproducible neuroimmune experiments around Ginsenoside Rg1, from solvent handling and dosing controls to gut–immune–brain readouts. This workflow translates anesthesia-associated findings into practical designs for neuroprotection research, apoptosis and inflammation research, and mechanistic Treg studies.

• A23187, Free Acid: Interpreting Calcium-Driven Death

  2026-09-14

  A23187, free acid is a calcium ionophore for dissecting how intracellular Ca2+ changes become signaling, growth inhibition, or cell death. This article pairs its mechanistic applications with a measurement framework that separates relative viability from fractional cell killing.

• Ziprasidone Hydrochloride Assay Guide

  2026-09-14

  A scenario-based guide to using Ziprasidone Hydrochloride in cell viability, proliferation, migration, and permeability workflows. It explains how SKU A5350 can support better-controlled dosing, interpretation of GOT1-related activity, and practical reagent selection.

• SFI, SRC/PI3K/AKT, and Glioma Mechanisms

  2026-09-13

  This study combines network pharmacology with cellular and mouse experiments to investigate how Shenqi Fuzheng injection suppresses glioma proliferation and migration. Its main contribution is the experimentally supported identification of SRC/PI3K/AKT signaling as a mechanistic axis associated with cell-cycle arrest, reduced migration, and slower tumor growth.

• MK-571: Separating Receptor and MRP1 Effects

  2026-09-12

  MK-571 (L-660,711) is a selective LTD4 receptor antagonist with important implications for airway and transporter assays. This article presents a practical framework for distinguishing leukotriene receptor pharmacology from ABCC1/MRP1-dependent effects in inflammation and macrophage research.

• TG003: From Splicing Control to CLK2 Translation

  2026-09-11

  TG003 connects Cdc2-like kinase biology with alternative splicing and platinum-resistance research. This thought-leadership guide explains how to use its Clk1/2/4 activity profile to design mechanistically disciplined experiments while distinguishing validated evidence from translational hypotheses.

8390 records 1/560 page Next 12345 下5页 Last page